Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1211531.RAZhM2jBQwC2w20Yy7arv1gOPtPVkuLrRsFXGf8ArgS28130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1211531.RAZhM2jBQwC2w20Yy7arv1gOPtPVkuLrRsFXGf8ArgS28130_assertion type Assertion NP1211531.RAZhM2jBQwC2w20Yy7arv1gOPtPVkuLrRsFXGf8ArgS28130_head.
- NP1211531.RAZhM2jBQwC2w20Yy7arv1gOPtPVkuLrRsFXGf8ArgS28130_assertion description "[Therefore, the NPY/Y5R pathway may become a novel therapeutic target for patients with refractory NB, thus far an incurable form of this disease.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1211531.RAZhM2jBQwC2w20Yy7arv1gOPtPVkuLrRsFXGf8ArgS28130_provenance.
- NP1211531.RAZhM2jBQwC2w20Yy7arv1gOPtPVkuLrRsFXGf8ArgS28130_assertion evidence source_evidence_literature NP1211531.RAZhM2jBQwC2w20Yy7arv1gOPtPVkuLrRsFXGf8ArgS28130_provenance.
- NP1211531.RAZhM2jBQwC2w20Yy7arv1gOPtPVkuLrRsFXGf8ArgS28130_assertion SIO_000772 25132261 NP1211531.RAZhM2jBQwC2w20Yy7arv1gOPtPVkuLrRsFXGf8ArgS28130_provenance.
- NP1211531.RAZhM2jBQwC2w20Yy7arv1gOPtPVkuLrRsFXGf8ArgS28130_assertion wasDerivedFrom befree-2016 NP1211531.RAZhM2jBQwC2w20Yy7arv1gOPtPVkuLrRsFXGf8ArgS28130_provenance.
- NP1211531.RAZhM2jBQwC2w20Yy7arv1gOPtPVkuLrRsFXGf8ArgS28130_assertion wasGeneratedBy ECO_0000203 NP1211531.RAZhM2jBQwC2w20Yy7arv1gOPtPVkuLrRsFXGf8ArgS28130_provenance.